Names without a link are companies not yet registered in OpenBizGraph
§05
Network
NETWORK
Loading the relationship graph...
Drag to move · click to open
§06
History
75 EVENTS
July 1940: Otojiro Shibata founded Shibata Pharmaceutical Works in Suita, Osaka Prefecture.
Shibata Onijiro founded Shibata Pharmaceutical in Suita City, Osaka Prefecture.
1943: Following the merger of 10 companies, Shibata Pharmaceutical Works became the Fourth Plant of Taiyo Pharmaceutical.
Shibata Pharmaceutical became the fourth factory of Taiyo Pharmaceutical through a joint venture of ten companies.
April 1946: Acquired the manufacturing and sales rights for Chuyu Seirogan (now “Seirogan”) from Nakajima Saichi Pharmacy.
Inherited the manufacturing and sales rights for Chūyū Seirōgan (now "Seirōgan") from Nakajima Saichi Pharmacy.
November 1946: Became independent from Taiyo Pharmaceutical and established Taiho Pharmaceutical Co., Ltd. in Suita, Osaka Prefecture; began sales of Chuyu Seirogan.
Established Daikō Pharmaceutical Co., Ltd. after separating from Taiyo Pharmaceutical and began selling Chūyū Seirōgan.
Establishment date: November 18, 1946
May 1954: Began exporting “Seirogan.”
Started exporting "Seirōgan".
April 1964: Opened the Tokyo Branch Office (now the Tokyo Office) in Ota-ku, Tokyo.
Opened a Tokyo branch office (now Tokyo Office) in Ota Ward, Tokyo.
October 1966: Began sales of “Seirogan Sugar-Coated Tablets.”
Started selling "Seirōgan Sugar Coated".
June 1972: Built the head office building and Suita Plant in Suita, Osaka Prefecture.
Constructed a headquarters building and a Suita factory in Suita City, Osaka Prefecture.
June 1979: Renovated the Suita Plant, bringing it into compliance with GMP.
Renovated the Suita factory to become a GMP-compliant facility.
November 1981: Began sales of “Seirogan Sugar-Coated Tablets A.”
Started selling "Seirōgan Sugar Coated A".
November 1990: Opened the Nagoya Branch Office (now the Nagoya Office) in Meito-ku, Nagoya, Aichi Prefecture.
Opened a Nagoya branch office (now Nagoya Office) in Meito Ward, Nagoya City, Aichi Prefecture.
November 1991: Built a research building in Suita, Osaka Prefecture, to enhance basic research.
Built a research building in Suita City, Osaka Prefecture to further enhance basic research.
March 1992: Established Taiho Creosote Co., Ltd. in Suita, Osaka Prefecture, to manufacture wood creosote, the main ingredient in “Seirogan.”
Established Daikō Creosote Co., Ltd. in Suita City, Osaka Prefecture to produce the main raw material, Japanese cedar creosote.
December 1996: Established Taiho Pharmaceutical Co., Ltd. in Taiwan to strengthen pharmaceutical sales in the Taiwanese market.
Established Daikō Pharmaceutical Co., Ltd. (Taiwan) to strengthen pharmaceutical sales in the Taiwanese market.
February 1997: Opened a Shenzhen office in China to conduct market research and collect pharmaceutical regulatory information.
Established a Shenzhen office in China for market research and regulatory information gathering.
November 2004: Established Taiho Pharmaceutical (Asia Pacific) Co., Ltd. in Hong Kong to strengthen sales.
Established Daikō Pharmaceutical (Asia Pacific) Ltd. in Hong Kong.
February 2005: Established Seirogan (International) Co., Ltd. to protect the “Seirogan” trademark in China, centered on Hong Kong.
Established Seirōgan (International) Ltd. in Hong Kong to protect the trademark of "Seirōgan" in China.
April 2005: Started selling hygiene management product 'Krevelin'.
Started selling hygiene product "Kurebin".
November 2005: To promote infection control business, acquired Shanghai Anbu Environmental Technology Co., Ltd. as a subsidiary and renamed it Daikyou Anbu Environmental Technology (Shanghai) Co., Ltd.
Acquired Ab Environmental Technology (Shanghai) Co., Ltd. and renamed it Daikō Ab Environmental Technology (Shanghai) Ltd. to promote infection control business.
March 2006: For expanding the infection control business, absorbed Business Plan Co., Ltd., which owns related patents.
Acquired and merged with Business Plan Co., Ltd., which owns related patents, to expand the infection control business.
March 2009: Listed shares on the Second Section of the Tokyo Stock Exchange.
Listed on the Second Section of the Tokyo Stock Exchange
April 2010: Designated to the First Section of the Tokyo Stock Exchange.
Designated on the First Section of the Tokyo Stock Exchange
December 2011: Moved Tokyo office to Minato-ku, Tokyo.
Relocated Tokyo office to Minato-ku, Tokyo
February 2012: Established Taiwan branch and transferred operations from Daikyou Pharmaceutical Co., Ltd.
Established a Taiwan branch and transferred operations from Da Xing Pharmaceutical Co., Ltd.
March 2013: Moved Nagoya office to Naka-ku, Nagoya, Aichi Prefecture.
Relocated Nagoya office to Nakanuma-ku, Nagoya City, Aichi Prefecture
March 2014: Moved headquarters functions to Nishi-ku, Osaka, Osaka Prefecture.
Relocated headquarters functions to Nishi-ku, Osaka City, Osaka Prefecture
August 2015: Established Kyoto factory and R&D center in Sekka-cho, Sagarakuni, Kyoto Prefecture.
Established Kyoto factory and R&D center in Sekka-cho, Sōraku-gun, Kyoto Prefecture
April 2017: Started selling 'Seirogan Quick C'.
Started sales of "Seirogan Quick C"
September 2019: Launched daily disinfection product brand 'Kreve & And'.
April 2020: Established Taiwan Daikyou Pharmaceutical Co., Ltd. in Taiwan and acquired the local Krevelin distributor's web sales business.
Established Taiwan Da Xing Pharmaceutical Co., Ltd. in Taiwan and acquired local Crevelin sales agency web business
May 2020: To accelerate pharmaceutical and infection control business in China, established Daikyou Pharmaceutical (Shenzhen) Co., Ltd. in Shenzhen.
Established Da Xing Pharmaceutical (Shenzhen) Co., Ltd. in Shenzhen, China
October 2020: Established Daikyou Pharmaceutical International Co., Ltd. in Nishi-ku, Osaka, Osaka Prefecture.
Established Da Xing Pharmaceutical International Co., Ltd. in Nishi-ku, Osaka City, Osaka Prefecture
November 2020: Established Ibaraki factory in Saicho, Ibaraki City, Osaka Prefecture.
Established Ibaraki factory in Saicho, Ibaraki City, Osaka Prefecture
January 2021: Closed Shenzhen office and integrated into Daikyou Pharmaceutical (Shenzhen) Co., Ltd.
Closed Shenzhen office and merged into Da Xing Pharmaceutical (Shenzhen) Co., Ltd.
October 2021: Closed Taiwan branch and integrated operations into Taiwan Daikyou Pharmaceutical Co., Ltd.
Closed Taiwan branch and integrated operations into Taiwan Da Xing Pharmaceutical Co., Ltd.
April 2022: Moved to the new Prime Market of the Tokyo Stock Exchange.
Transitioned to the Prime Market of the Tokyo Stock Exchange
August 2023: Moved Tokyo office to Shibaura, Minato-ku, Tokyo.
Relocated Tokyo office to Shibaura, Minato-ku, Tokyo
§07
News
5 ARTICLES
Notice and Request from Daiko Pharmaceutical Co., Ltd.
On May 27, 2026, Daiko Pharmaceutical issued a warning regarding products mistakenly sold through online shopping advertisements. The relevant products are from other companies and are not products of the company. They are cautioning customers to avoid misunderstandings.
Misconceptions and Warnings Regarding the Sale of Seirogan
Daikou Pharmaceutical clearly states that the product mistakenly identified as being sold by the 'Seirogan company' in online advertising is actually a product from another company and not their own. They also state that they cannot provide answers regarding that product in response to customer inquiries.
Taiko Pharmaceutical Announces Official Apparel Line and Eco-Friendly Packaging
Taiko Pharmaceutical released original T-shirts inspired by Seirogan and also changed to environmentally friendly packaging. Additionally, they donated disaster prevention whistles to an elementary school in Suita City, Osaka Prefecture, where the company was founded.
Daiko Pharmaceutical Media Information and Product Introduction
As of April 1, 2020, Daiko Pharmaceutical was ranked first in the Kansai region's corporate market capitalization growth rate ranking. Multiple media outlets have introduced products and initiatives such as 'Kurebelling' and 'Kurebe & And,' responding to the increased demand for hygiene measures due to the impact of the novel pneumonia.
Daikou Pharmaceutical ranks first among Kansai companies in market capitalization growth rate
On April 1, 2020, the Osaka edition of the Nikkei newspaper reported that Daikou Pharmaceutical was ranked first in the 2019 market capitalization growth rate ranking among Kansai companies.
§08
Public records
GOV
National Tax Agency basic information2120901007344
Source: National Tax Agency Corporate Number Publication Site, basic three items
Trade name
大幸薬品株式会社
Trade name (kana)
タイコウヤクヒン
Name in English
Corporation type
301
Address
〒564-0032 大阪府吹田市内本町3丁目34番14号
Postal code
5640032
Prefecture code
27
City code
205
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2018-04-16
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
4077459
METI gBizINFO2120901007344
Source: gBizINFO (Ministry of Economy, Trade and Industry)